Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
This cell will serve as an extension of the Tele Mental Health Assistance and Networking Across States initiative of the Ministry of Health and Family welfare
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
The product is expected to be launched in FY25
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Almost 300 million people globally have chronic hepatitis B
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Subscribe To Our Newsletter & Stay Updated